Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne.
VS Caremark announced on Wednesday a donation of more than $100,000 to the American Red Cross National Disaster Relief Fund to provide support to communities that have been affected by Hurricane Sandy.
Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.
Unilever’s men’s grooming brand Axe has launched its "Getting Dressed" creative spot in the United States, which takes a lighter look at a couple's interaction the morning after a romantic chance encounter.
The Food and Drug Administration has approved a Type 2 diabetes drug made by Watson Pharmaceuticals, the company said, following a federal court's order for the agency to approve the drug.
Health and beauty products manufacturer CCA Industries — whose brands include Plus+White toothpastes and teeth whiteners, Nutra Nail nail care treatments and Gel Perfect UV-free gel color — announced that its board has approved the company’s 34th consecutive dividend.
Palmer's Cocoa Butter Formula has joined the World Cocoa Foundation in support of efforts to provide economic, social and environmental development in cocoa-growing communities.
Sneaky Pete's Naturally Oatstanding Beverage is now available at various grocery stores and other retailers nationwide. The first soluble oat beverage of its kind, Sneaky Pete's is an easy and low-calorie way for consumers to meet the daily requirement for fiber.
The Food and Drug Administration has approved what it called the first drug to treat an eye condition that can interfere with the part of the retina responsible for reading vision.
Par Pharmaceutical Cos. has entered into agreements with Watson Pharmaceuticals and Actavis to purchase five generic products currently marketed in the United States by Watson or Actavis, eight abbreviated new drug applications currently awaiting regulatory approval, and a generic product in late-stage development.
Watson Pharmaceuticals announced that its subsidiary, Watson Laboratories, has received Food and Drug Administration approval on its abbreviated new drug application for irbesartan tablets — the generic equivalent to Sanofi's Avapro — in the 75-mg, 150-mg and 300-mg strengths.
Medical supply company BD has introduced a disposable injection pen that it said was designed for drugs requiring frequent, low-volume injections or variable dosing.